Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms

Disease Markers

Volumn 27, Issue 5, 2009, Pages 217-223

  Menegatti, Elisa ^a   Davit, Annalisa ^a   Francica, Simona ^a   Berardi, Daniela ^a   Rossi, Daniela ^b   Baldovino, Simone ^a   Tovo, Pier Angelo ^a   Sena, Luigi M ^a   Roccatello, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ematologiche Ed Immunoematologiche   (Italy)

Author keywords

Connective diseases; Polymorphisms; Systemic vasculitis; Uteroglobin

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; THREONINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UTEROGLOBIN;

ADULT; AGED; ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; ARTICLE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROPOLYANGIITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC VASCULITIS; VASCULITIS;

EID: 77249161650     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/435108     Document Type: Article

References (26)

1. E. Menegatti, A. Nardacchione, M. Alpa, C. Agnes, D. Rossi, M. Chiara, V. Modena, L.M. Sena and D. Roccatello, Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy, Lab Invest 82 (2002), 543-546.
2. Y.H. Lee, J.B. Harley and S.K. Nath, Meta-analysis of TNFalpha promoter -308 A/G polymorphism and SLE susceptibility, Eur J Hum Genet 14 (2006), 364-371.
3. D.L. Mattey, N. Nixon, P.T. Dawes and J. Kerr, Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis, Ann Rheum Dis 64 (2005), 1190-1194.
4. H. Schmeling, U.Wagner, A. Peterson and G. Horneff, Tumor necrosis factor alpha promoter polymorphisms in patients with juvenile idiopathic arthritis, Clin Exp Rheumatol 24 (2006), 103-108.
5. G. Schett, Review: Immune cells and mediators of inflammatory arthritis, Autoimmunity 41 (2008), 224-229.
6. M. Aringer, E. Feierl, G. Steiner, G.H. Stummvoll, E. Höfler, C.W. Steiner, I. Radda, J.S. Smole and W.B. Graninger, Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death, Lupus 11 (2002), 102-108.
7. A.B. Mukherjee, Z. Zhang and B.S. Chilton, Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily, Endocr Rev 28 (2007), 707-725.
8. I.A. Laing, C. Hermans, A. Bernard, P.R. Burton, J. Goldblatt and P.N. Le Souëf, Association between plasma CC16 levels, the A38G polymorphism, and asthma, Am J Respir Crit Care Med 161 (2000), 124-127.
9. A.W. Gibson, J.C. Edberg, J. Wu, R.G. Westendorp, T.W. Huizinga and R.P. Kimberly, Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus, J Immunol 166 (2001), 3915-3922.
10. A.M. Dunning, P.D. Ellis, S. McBride, H.L. Kirschenlohr, C.S. Healey, P.R. Kemp, R.N. Luben, J. Chang-Claude, A. Mannermaa, V. Kataja, P.D. Pharoah, D.F. Easton, B.A. Ponder and J.C. Metcalfe, A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer, Cancer Res 63 (2003), 2610-2615.
11. M. Yokota, S. Ichihara, T.L. Lin, N. Nakashima and Y. Yamada, Association of a T29?C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese, Circulation 101 (2000), 2783-2787.
12. W.P. Arend, M. Malyak, C.J. Guthridge and C. Gabay, Interleukin-1 receptor antagonist: role in biology, Annu Rev Immunol 16 (1998), 27-55.
13. J.K. Tarlow, A.I. Blakemore, A. Lennard, R. Solari, H.N. Hughes, A. Steinkasserer and G.W. Duff, Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat, Hum Genet 91 (1993), 403-404.
14. A.I. Blakemore, J.K. Tarlow, M.J. Cork, C. Gordon, P. Emery and G.W. Duff, Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus, Arthritis Rheum 37 (1994), 1380-1385.
15. G. Bioque, J.B. Crusius, I. Koutroubakis, G. Bouma, P.J. Kostense, S.G. Meuwissen and A.S. Peña, Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease, Clin Exp Immunol 102 (1995), 379-383.
16. A.I. Blakemore, P.F. Watson, A.P. Weetman and G.W. Duff, Association of Graves' disease with an allele of the interleukin- 1 receptor antagonist gene, J Clin Endocrinol Metab 80 (1995), 111-115.
17. S. Beinke and S.C. Ley, Functions of NF-B1 and NF-B2 in immune cell biology, Biochem J 382 (2004), 393-409.
18. G. Cees and M. Kallemberg, The last classification of vasculitis, Clinic Rev Allerg Immunol 35 (2008), 5-10.
19. B.A. Michel, G.G. Hunder, D.A. Bloch and L.H. Calabrese, Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders, J Rheumatol 19 (1992), 721-728.
20. D. Roccatello, A. Fornasieri, O. Giachino, D. Rossi, A. Beltrame, G. Banfi, R. Confalonieri, A. Tarantino, S. Pasquali, A. Amoroso, S. Savoldi, V. Colombo, C. Manno, A. Ponzetto, L. Moriconi, A. Pani, R. Rustichelli, G.B. Di Belgiojoso, C. Comotti and M.I. Quarenghi, Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis, Am J Kidney Dis 49 (2007), 69-82.
21. I. Dierynck, A. Bernard, H. Roels and M. De Ley, Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16, Am J Respir Cell Mol Biol 12 (1995), 205-210.
22. X.L. Yao, S.J. Levine, M.J. Cowan, C. Logun and J.H. Shelhamer, Tumor necrosis factor-alpha stimulates human Clara cell secretory protein production by human airway epithelial cells, Am J Respir Cell Mol Biol 19 (1998), 629-635. (Pubitemid 128354245)
23. J.J. Goronzy, E.L. Matteson, J.W. Fulbright, K.J. Warrington, A. Chang-Miller, G.G. Hunder, T.G. Mason, A.M. Nelson, R.M.Valente, C.S. Crowson, H.A. Erlich, R.L. Reynolds, R.G. Swee, W.M. O'Fallon and C.M. Weyand, Prognostic markers of radiographic progression in early rheumatoid arthritis, Arthritis Rheum 50 (2004), 43-54.
24. E.M. Eisenstein and M. Choi, Analysis of a uteroglobin gene polymorphism in childhood Henoch-Schonlein purpura, Pediatr Nephrol 21 (2006), 782-784.
25. S. Bacher and M.L. Schmitz, The NF-B pathway as a potent target for autoimmune disease theraphy, Curr Pharm Design 10 (2004), 2827-2837.
26. E. Dejardin, The alternative NF-B pathway from biochemistry to biology: pitfalls and promises for future drug development, Biochem Pharmacol 72 (2006), 1161-1179.